Key result
Monitoring sdLDL-C predicts atherosclerosis and cardiovascular risk in patients with T2D and hypertension.
Why the study?
Patients with type 2 diabetes mellitus and hypertension frequently have lipid metabolism disorders and vascular endothelial dysfunction leading to atherosclerosis, where sdLDL-C may predict disease progression and cardiovascular risk.
Does monitoring sdLDL-C levels improve prediction of atherosclerosis and cardiovascular risk in individuals with T2DM and hypertension?
Does monitoring sdLDL-C levels improve prediction of atherosclerosis and cardiovascular risk in individuals with T2DM and hypertension?
Monitoring sdLDL-C levels in patients with T2DM and hypertension may aid in the early prediction and prevention of atherosclerosis and cardiovascular events.
临床观察表明，同时罹患2型糖尿病(T2DM)和高血压的个体普遍存在脂质代谢紊乱及血管内皮功能障碍，进一步可进展为动脉粥样硬化，小而密低密度脂蛋白(sdLDL-C)亚型在预测动脉粥样硬化进程和评估心血管事件风险方面具有重要的临床价值。因此，加强对这类患者sdLDL-C水平的监测，有助于更早实施干预措施，实现早期预防和治疗。Clinical observations indicate that lipid metabolism disorders and vascular endothelial dysfunction are prevalent in individuals with type 2 diabetes mellitus (T2DM) and hypertension, which can further progress to atherosclerosis. Small and dense low-density lipoprotein (sdLDL-C) subtypes have important clinical value in predicting the progression of atherosclerosis and assessing the risk of cardiovascular events. Therefore, strengthening the monitoring of sdLDL-C levels in such patients will help to implement interventions earlier and achieve early prevention and treatment.
No takes yet. Share an insight, caveat, or question.
阳阳 付 (2025) conducted a review in Type 2 diabetes mellitus and hypertension. Monitoring of sdLDL-C levels was evaluated. Monitoring small and dense low-density lipoprotein (sdLDL-C) levels in patients with type 2 diabetes and hypertension has important clinical value for predicting atherosclerosis and cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: